| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.24B | 2.02B | 1.79B | 2.14B | 1.63B |
| Gross Profit | 526.89M | 465.59M | 426.90M | 554.93M | 408.75M |
| EBITDA | 251.61M | 230.85M | 219.35M | 324.58M | 223.71M |
| Net Income | 190.55M | 171.04M | 157.82M | 240.55M | 197.70M |
Balance Sheet | |||||
| Total Assets | 1.49B | 1.41B | 1.35B | 1.31B | 1.15B |
| Cash, Cash Equivalents and Short-Term Investments | 273.26M | 376.07M | 370.96M | 286.40M | 264.24M |
| Total Debt | 30.75M | 45.14M | 35.15M | 36.56M | 24.78M |
| Total Liabilities | 387.96M | 342.06M | 320.75M | 330.47M | 323.69M |
| Stockholders Equity | 1.10B | 1.06B | 1.03B | 976.29M | 830.46M |
Cash Flow | |||||
| Free Cash Flow | 232.09M | 157.07M | 207.26M | 211.59M | 125.57M |
| Operating Cash Flow | 267.49M | 178.50M | 224.68M | 255.69M | 144.22M |
| Investing Cash Flow | -222.44M | -23.95M | -31.71M | -129.34M | -159.10M |
| Financing Cash Flow | -162.79M | -147.95M | -107.71M | -102.20M | -65.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $4.12B | 21.82 | 17.55% | ― | 11.36% | 15.51% | |
76 Outperform | $2.90B | 9.77 | 16.38% | ― | -6.58% | -18.09% | |
70 Outperform | $3.37B | 9.52 | 11.42% | ― | -1.83% | -30.18% | |
70 Outperform | $4.04B | 19.42 | 13.56% | ― | 7.26% | 6.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $3.06B | 8.68 | 9.01% | 1.76% | -13.61% | -37.18% |